Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive
    Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive
    • News

  • Semtech and EMASS Bring Intelligence to the Edge as AI Meets Long-Range IoT
    Semtech and EMASS Bring Intelligence to the Edge as AI Meets Long-Range IoT
    • News

  • Control Bionics Moves to Fully Acquire NeuroBounce Program as EMG-Based Performance Tech Gains Momentum
    Control Bionics Moves to Fully Acquire NeuroBounce Program as EMG-Based Performance Tech Gains Momentum
    • News

  • SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    SKS Technologies Moves to Expand NSW Footprint With Delta Elcom Acquisition
    • News

  • Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    Monash University Partners with HITIQ to Advance Concussion Science Using Smart Mouthguards
    • News

  • Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    • News

  • Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    Pivotal Metals Secures $5.4M to Fast-Track Quebec Drill Program
    • News

  • Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    Biotron Expands into Anaesthetics with Sedarex Acquisition and $2.5m Raise
    • News

  • DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    DroneShield Boosts Defence Capability with $13 Million Adelaide R&D Investment
    • News

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

Adamantem tags in with competing bid with Rouse in fight to acquire QANTM

  • In News
  • March 12, 2024
  • Alinda Gupta
Adamantem tags in with competing bid with Rouse in fight to acquire QANTM

Since last month, intellectual property services provider QANTM (ASX: QIP) has come into the spotlight following strong H1 FY24 results. So much so that it caught the eye of three companies wanting to acquire it.

QANTM capitalises on the growth of the broader intellectual property rights industry. Australian businesses with IP rights account for around 35% of Australia’s Gross Domestic Product (GDP) and jobs for 2.6 million Australian workers.

Responding to media speculation from the AFR, the Company confirmed that it has received a non-binding indicative offer from the Sydney buyout firm Adamantem Capital in relation to a potential acquisition of all the shares in QANTM for $1.817 per share by way of a scheme of arrangement. This follows a proposal from the UK-based IP company Rouse, revealed in a similar fashion following speculation.

QANTM owns a group of intellectual property (IP) services businesses in Australia, New Zealand, Singapore, Malaysia and Hong Kong under key brands Davies Collison Cave, DCC Advanz Malaysia, Davies Collison Cave Law, FPA Patent Attorneys, and Sortify.tm Ltd. It provides services across the IP value chain to a broad range of Australian and international clients, ranging from start-up technology businesses to Fortune 500 multinationals, public research institutions and universities.

The bidding war follows QANTM’s strong financial performance in H1 FY24, when the Company posted its best result since listing. Its service charges grew by 9.2% on PCP, patents were up 6.6% to $37.8m, trademarks up 7% to $11.1m and legal services up 27.3% to $7.9m.

The total revenue saw 8.1% growth on H1 FY23 to $74.2m. NPAT rose by 43.4% to $7.4m while earnings stood at $16m. 

The Adamantem Indicative Proposal is all cash with a scrip election of up to 50%. On the other hand, the Rouse proposal has not had its details fully disclosed.

Adamantem is an Australian-based private equity investor while Rouse is a UK-based international intellectual property firm operating in 12 jurisdictions, with a significant emphasis on the Asia Pacific region. It is highly complementary in both geographic and service lines to QANTM. But it does not have a physical presence in Australia. 

Rouse made its bid on February 27, 2024, around the same time when competitors Quadrant Private Equity and Adamantem Capital indicated their interest, too.

QANTM noted that the Adamantem Indicative Proposal represents a higher price than the Rouse Indicative Proposal, but has not yet been comprehensively assessed by the QANTM Board.  

As of now, no agreement has been reached between QANTM and any party in relation to the value, structure or terms of a transaction. 

The QANTM Board has asked shareholders to take no action in regard to either proposal.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • asx qip
  • intellectual property
  • IP
  • QANTM
  • qip
  • ROuse
  • trademarks
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.